Events

Rappel de CAPIO PGA (POLGLYCOLIC ACID) COATED BRAIDED

Selon Health Canada (via FOI), ce/cet/cette rappel concerne un dispositif en/au/aux/à Canada qui a été fabriqué par BOSTON SCIENTIFIC LTD..

Qu'est-ce que c'est?

Une correction ou un retrait opéré par un fabricant afin de répondre à un problème causé par un dispositif médical. Les rappels surviennent lorsqu'un dispositif médical est défectueux, lorsqu'il pourrait poser un risque pour la santé, ou les deux à la fois.

En savoir plus sur les données ici
  • Type d'événement
    Recall
  • ID de l'événement
    106222
  • Classe de risque de l'événement
    II
  • Date de mise en oeuvre de l'événement
    2007-06-26
  • Pays de l'événement
    Canada
  • Source de l'événement
    HC
  • Notes / Alertes
    Canadian data is current through March 2018. All of the data comes from Health Canada, except for the categories Manufacturer Parent Company and Product Classification.
    The Parent Company and the Product Classification were added by ICIJ.
    The parent company information is based on 2017 public records. The device classification information comes from FDA’s Product Classification by Review Panel, based on matches of recall data from the U.S. and Canada.
  • Notes supplémentaires dans les données
  • Cause
    The products may not meet their final performance specification for suture tensile strength which could lead to premature breakage. in addition the bullet shaped needle could detach from the suture.

Device

CAPIO PGA (POLGLYCOLIC ACID) COATED BRAIDED
  • Modèle / numéro de série
    Model Catalog: (Lot serial: ); Model Catalog: (Lot serial: CATALOGUE # 833-213); Model Catalog: (Lot serial: CATALOGUE # 833-114); Model Catalog: (Lot serial: CATALOGUE # 833-136); Model Catalog: (Lot serial: CATALOGUE # 833-137)
  • Description du dispositif
    CAPIO PGA SUTURE
  • Manufacturer
    BOSTON SCIENTIFIC LTD.

Manufacturer

BOSTON SCIENTIFIC LTD.
  • Adresse du fabricant
    MISSISSAUGA
  • Société-mère du fabricant (2017)
    Boston Scientific
  • Commentaire du fabricant
    “We take a patient-first approach to assessing the applicability of every recall and communicate to regulatory bodies in all geographies where the recalled device is sold,” Boston Scientific said in a statement to ICIJ. “We have coordinated several recalls across many countries in a timely manner,” the company said, adding that it complies with all national laws, which can often vary and require different processes for reporting information or taking action on recalls. The company said it uses a rigorous and uniform process to take action on recalls and that “when we initiate a field action (e.g. recall, safety alert), every customer who has received an affected product receives a communication that includes a letter for the physician.”
  • Source
    HC